Intensive group treatment for children with selective mutism: a pilot study with repeated assessments
Related Experiment Video
Updated: Nov 4, 2026

A Treatment Package without Escape Extinction to Address Food Selectivity
Published on: August 21, 2015
Christina Schwenck1, Megan Williams2, Jana Zimmermann-Hauel2
1Department of Clinical Child and Adolescent Psychology, Justus-Liebig-University Giessen, Otto-Behaghel-Str. 10, 35394, Giessen, Germany. christina.schwenck@psychol.uni-giessen.de.
Background:
Selective mutism (SM) is an anxiety disorder characterized by a persistent failure to speak in specific social situations despite speaking normally in others. Preliminary evidence suggests that intensive behavioral group interventions may be a promising treatment approach. This pilot study evaluated the outcomes of such an intervention for children with SM for the first time in a German clinical sample.
Methods:
Sixteen children aged five to nine with SM were included in the study and fifteen participated in an intensive group intervention based on Parent-Child-Interaction Therapy for Selective Mutism (PCIT-SM). Two baseline, one post-treatment, and one three-month follow-up assessments were conducted. Primary outcome was parent-rated SM symptom severity assessed with the Frankfurt Scale for Selective Mutism (FSSM). Remission status based on a structured clinical interview served as secondary outcome. Changes over time were analyzed using linear mixed-effects models and Cochran's Q tests.
Results:
SM symptom severity decreased significantly over time with large effects from baseline 1 to post-treatment (dRM = 1.03) and follow-up (dRM = 1.69). No significant differences emerged between the two baseline assessments. Remission rates increased from 0% at first baseline to 47% at follow-up. A significant overall change in diagnostic status across assessments was observed. Exploratory analyses further showed that general anxiety decreased from baseline to follow-up.
Conclusions:
The findings provide preliminary support for intensive group interventions based on PCIT-SM principles as a promising treatment for children with SM. Future controlled studies with larger samples and longer follow-up periods are needed to evaluate treatment mechanisms and long-term outcomes. Trial registration German Clinical Trials Register (DRKS), DRKS00040917, retrospectively registered on 13 July 2026.
